Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956233676> ?p ?o ?g. }
- W2956233676 endingPage "2358" @default.
- W2956233676 startingPage "2351" @default.
- W2956233676 abstract "Background and Purpose— Flow diverter technology improvements are necessary to provide safe and good results and enable the treatment of a larger variety of aneurysms. We report a nationwide experience with the Derivo Embolization Device in the treatment of intracranial aneurysms. Methods— BRAIDED (Brazilian Registry of Aneurysms Assigned to Intervention With the Derivo Embolization Device) is a multicenter, prospective, interventional, single-arm trial of the Derivo Embolization Device for the treatment of intracranial aneurysms. The primary effectiveness end point was total aneurysm occlusion at 6- and 12-month angiographies. The secondary safety end point was the absence of serious adverse events during follow-up. Univariable and multivariable logistic regression was performed to identify predictors of aneurysm persistence, periprocedural complications, and adverse events during follow-up. Results— Between December 2016 and October 2018, 146 patients harboring 183 intracranial aneurysms were treated in 151 interventions at 7 centers. Derivo Embolization Device placement was technically successful in all patients. Most aneurysms (86.9%) were located at the internal carotid artery, and the mean diameter was 6.7 mm. At 6 months, 113 of 140 (80.7%) aneurysms met the study’s primary end point, and 74 of 83 (89.2%) met the study’s primary end point at 12 months. Saccular morphology of the aneurysm (odds ratio, 5.66; 95% CI, 1.01–31.77) and the presence of a branch arising from the sac (odds ratio, 6.36; 95% CI, 2.11–22.36) predicted persistence. A long duration of follow-up (odds ratio, 0.86; 95% CI, 0.78–0.95) predicted total occlusion. Of the 146 enrolled patients, 138 (94.5%) were treated without serious adverse events during follow-up. In the multivariable analysis, aneurysms located at a sidewall were less likely to experience these events than those located at bifurcations (odds ratio, 0.07; 95% CI, 0.01–0.51). Conclusions— The Derivo Embolization Device is a safe and effective treatment for intracranial aneurysms. Clinical Trial Registration— URL: http://plataformabrasil.saude.gov.br/login.jsf . Unique identifier: CAAE 77089717.7.1001.5125." @default.
- W2956233676 created "2019-07-23" @default.
- W2956233676 creator A5001666658 @default.
- W2956233676 creator A5005687629 @default.
- W2956233676 creator A5006286725 @default.
- W2956233676 creator A5014578593 @default.
- W2956233676 creator A5016006528 @default.
- W2956233676 creator A5017610731 @default.
- W2956233676 creator A5023865242 @default.
- W2956233676 creator A5028100162 @default.
- W2956233676 creator A5037935248 @default.
- W2956233676 creator A5047154789 @default.
- W2956233676 creator A5048982414 @default.
- W2956233676 creator A5064288960 @default.
- W2956233676 creator A5065255052 @default.
- W2956233676 creator A5072294192 @default.
- W2956233676 creator A5083549089 @default.
- W2956233676 creator A5090479545 @default.
- W2956233676 date "2019-09-01" @default.
- W2956233676 modified "2023-09-26" @default.
- W2956233676 title "Derivo Embolization Device for the Treatment of Intracranial Aneurysms" @default.
- W2956233676 cites W1971345237 @default.
- W2956233676 cites W2056227825 @default.
- W2956233676 cites W2083461513 @default.
- W2956233676 cites W2113516725 @default.
- W2956233676 cites W2124360594 @default.
- W2956233676 cites W2138004881 @default.
- W2956233676 cites W2138123546 @default.
- W2956233676 cites W2149285581 @default.
- W2956233676 cites W2163179455 @default.
- W2956233676 cites W2220668073 @default.
- W2956233676 cites W2320948110 @default.
- W2956233676 cites W2325656868 @default.
- W2956233676 cites W2345744740 @default.
- W2956233676 cites W2475610643 @default.
- W2956233676 cites W2604204200 @default.
- W2956233676 cites W2605621837 @default.
- W2956233676 cites W2743173943 @default.
- W2956233676 cites W2743889981 @default.
- W2956233676 cites W2784493672 @default.
- W2956233676 cites W2795702490 @default.
- W2956233676 cites W2806460109 @default.
- W2956233676 cites W2885547805 @default.
- W2956233676 cites W2891712608 @default.
- W2956233676 cites W4256110463 @default.
- W2956233676 doi "https://doi.org/10.1161/strokeaha.119.025407" @default.
- W2956233676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31288675" @default.
- W2956233676 hasPublicationYear "2019" @default.
- W2956233676 type Work @default.
- W2956233676 sameAs 2956233676 @default.
- W2956233676 citedByCount "22" @default.
- W2956233676 countsByYear W29562336762020 @default.
- W2956233676 countsByYear W29562336762021 @default.
- W2956233676 countsByYear W29562336762022 @default.
- W2956233676 countsByYear W29562336762023 @default.
- W2956233676 crossrefType "journal-article" @default.
- W2956233676 hasAuthorship W2956233676A5001666658 @default.
- W2956233676 hasAuthorship W2956233676A5005687629 @default.
- W2956233676 hasAuthorship W2956233676A5006286725 @default.
- W2956233676 hasAuthorship W2956233676A5014578593 @default.
- W2956233676 hasAuthorship W2956233676A5016006528 @default.
- W2956233676 hasAuthorship W2956233676A5017610731 @default.
- W2956233676 hasAuthorship W2956233676A5023865242 @default.
- W2956233676 hasAuthorship W2956233676A5028100162 @default.
- W2956233676 hasAuthorship W2956233676A5037935248 @default.
- W2956233676 hasAuthorship W2956233676A5047154789 @default.
- W2956233676 hasAuthorship W2956233676A5048982414 @default.
- W2956233676 hasAuthorship W2956233676A5064288960 @default.
- W2956233676 hasAuthorship W2956233676A5065255052 @default.
- W2956233676 hasAuthorship W2956233676A5072294192 @default.
- W2956233676 hasAuthorship W2956233676A5083549089 @default.
- W2956233676 hasAuthorship W2956233676A5090479545 @default.
- W2956233676 hasBestOaLocation W29562336761 @default.
- W2956233676 hasConcept C126322002 @default.
- W2956233676 hasConcept C126838900 @default.
- W2956233676 hasConcept C141071460 @default.
- W2956233676 hasConcept C156957248 @default.
- W2956233676 hasConcept C168563851 @default.
- W2956233676 hasConcept C188816634 @default.
- W2956233676 hasConcept C203092338 @default.
- W2956233676 hasConcept C2776035437 @default.
- W2956233676 hasConcept C2776098176 @default.
- W2956233676 hasConcept C2776268601 @default.
- W2956233676 hasConcept C44249647 @default.
- W2956233676 hasConcept C71924100 @default.
- W2956233676 hasConceptScore W2956233676C126322002 @default.
- W2956233676 hasConceptScore W2956233676C126838900 @default.
- W2956233676 hasConceptScore W2956233676C141071460 @default.
- W2956233676 hasConceptScore W2956233676C156957248 @default.
- W2956233676 hasConceptScore W2956233676C168563851 @default.
- W2956233676 hasConceptScore W2956233676C188816634 @default.
- W2956233676 hasConceptScore W2956233676C203092338 @default.
- W2956233676 hasConceptScore W2956233676C2776035437 @default.
- W2956233676 hasConceptScore W2956233676C2776098176 @default.
- W2956233676 hasConceptScore W2956233676C2776268601 @default.
- W2956233676 hasConceptScore W2956233676C44249647 @default.
- W2956233676 hasConceptScore W2956233676C71924100 @default.
- W2956233676 hasIssue "9" @default.